We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Diego Hernandez, PhD

Position:

Researcher

E-mail:

d.hernandez@dkfz-heidelberg.de

Phone:

+49 6221 42-1915

Fax:

+49 6221 42-1919

Dr. Diego Hernandez has extensive experience in formulating strategies and recommendations based on quantitative methods, in particular for panel data. His main research areas include the estimation of lung cancer treatment costs from a payers' perspective, the socioeconomic impact of cancer on patients and families and the comparison of Health Technology Assessments (HTAs) outcomes across national institutions.

Before joining the DKFZ, Diego worked as a consultant for the market research company Euromonitor and as a research assistant to the Chair of International Politics and Development Policy of Heidelberg University, where he received his doctorate in economics. His professional experience also included consulting work for the government of Indonesia, measuring the effectiveness of a national money transfer program in terms of health and education outcomes.

Selected Publications

D. Hernandez, C.-Y. Cheng, K. Hernandez-Villafuerte, M. Schlander:
Survival and comorbidities in lung cancer patients: evidence from administrative claims data in Germany
Oncology Research 2022, 30(4), 173-185.
DOI: 10.32604/or.2022.027262

D. Hernandez, M. Schlander:
Income loss after a cancer diagnosis in Germany: An analysis based upon the socio-economic panel survey.
Cancer Medicine, (2021) 10(11) 3726-3740.
DOI: 10.1002/cam4.3913

J. Schneider, D. Hernandez, CAESAR study group, M. Schlander, V. Arndt:
Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany: A multi-regional population-based study.
Journal of Cancer Survivorship, (2022): 1-21.
DOI: 10.1007/s11764-022-01293-x